Company information (Details) $ in Thousands, € in Millions |
Oct. 30, 2025
USD ($)
|
Jul. 07, 2023
EUR (€)
|
Jul. 07, 2023
USD ($)
|
|---|---|---|---|
| Janssen | |||
| Disclosure Of Information Related To The Company | |||
| Deal value | € | € 2,700.0 | ||
| Janssen | Top of Range | |||
| Disclosure Of Information Related To The Company | |||
| Potential development and commercial milestones payments | $ 650,000 | ||
| Collaboration agreement, compensation per indication | 220,000 | ||
| Janssen | Nanobiotix Corp. | Top of Range | |||
| Disclosure Of Information Related To The Company | |||
| Collaboration agreement, compensation per indication | 220.0 | $ 220,000 | |
| Janssen | Major ordinary share transactions | |||
| Disclosure Of Information Related To The Company | |||
| Deal value | € | 2,600.0 | ||
| Potential development and commercial milestones payments | € | € 105.0 | ||
| Royalty Financing Agreement | |||
| Disclosure Of Information Related To The Company | |||
| Aggregate nominal amount | $ 2,500 | ||
| Aggregate consideration amount | $ 71,000 |